Pro-nucleotides - Recent advances in the design of efficient tools for the delivery of biologically active nucleoside monophosphates

Synlett

Volumn , Issue 3, 1998, Pages 233-242

  Meier, C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26844445742     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1998-1637     Document Type: Article

References (114)

1. (a) De Clercq, E. J. Med. Chem. 1986, 29, 1561-1569.
2. (b) De Clercq, E. J. Med. Chem. 1995, 38, 2491-2517.
3. (c) Périgaud, C.; Gosselin, G.; Imbach, J.-L. Nucleosides & Nucleotides 1992, 11, 903-945.
4. (a) Herdewijn, P.; Balzarini, J.; De Clercq, E. in: Advances in Antiviral Drug Design. (Ed. De Clercq, E.), 1993, Vol. 1, 233-318.
5. (b) Herdewijn, P.; Balzarini, J.; De Clercq, E.; Pauwels, R.; Baba, M.; Broder, S.; Vanderhaeghe, H. J. Med. Chem. 1987, 30, 1270-1278.
6. (c) Mitsuya, H.; Broder, S. Proc. Natl. Acad. Sci., USA 1986, 83, 1911-1915.
7. Furman, P.A.; Fyfe, J.A.; St. Clair, M.H.; Weinhold, K.; Rideout, J.L.; Freeman, G.A.; Lehrmann, S.N.; Bolognesi, D.P.; Broder, S. Proc. Natl. Acad. Sci., USA 1986, 83, 8333-8337.
8. (a) Balzarini, J. Pharm. World Sci. 1994, 16, 113-126.
9. (b) Hao, Z.; Cooney, D.A.; Hartman, N.R.; Perno, C.-F.; Fridland, A.; DeVico, A.L.; Sarngadharan, M.G.; Broder, S.; Johns, D.G. Mol. Pharmacol 1988, 54, 431-435.
10. (a) Riddler, S.A.; Andersen, R.E.; Mellors, J.W. Antiviral Res. 1995, 27, 189-203.
11. (b) Hitchcock, M.J.M. Antiviral Chem Chemother. 1991, 2, 125-132.
12. (c) Ho, H.-T.; Hitchcock, M.J.M. Antimicrob. Agents Chemother. 1989, 33, 844-849.
13. (d) Baba, M.; Pauwels, R.; Herdewijn, P.; De Clercq, E.; Desmyter, J.; Vandeputte, M. Biochem. Biophys. Res. Commun. 1987, 142, 128-134.
14. (e) Mansuri, M.M.; Starrett Jr, J.E.; Ghazzouli, I.; Hitchcock, M.J.M.; Sterzycki, R.Z.; Brankovan, V.; Lin, T.-S.; August, E.M.; Prusoff, W.H.; Sommadossi, J.-P.; Martin, J.C. J. Med. Chem. 1989, 32, 461-466.
15. (f) Lin, T.-S.; Schinazi, R.F.; Prusoff, W.H. Biochem. Pharmacol. 1987, 36, 2713-2718.
16. (g) Zhu, Z.; Ho, H.-T.; Hitchcock, M.J.M.; Sommadossi, J.-P. Biochem. Pharmacol. 1990, 39, R15-R19.
17. (a) Balzarini, J.; Herdewijn, P.; De Clercq, E. J. Biol. Chem. 1989, 264, 6127-6133.
18. (b) Balzarini, J.; Kang, G.-J.; Dalal, M.; Herdewijn, P.; De Clercq, E.; Broder, S.; Johns, D.G. Mol. Pharmacol. 1987, 32, 162-167.
19. (c) Sommadossi, J.-P. J. Infect. Dis. 1995, 171, S88-S92.
20. Hao, Z.; Cooney, D.A.; Farquhar, D.; Perno, C.-F.; Zhang, K.; Masood, R.; Wilson, Y.; Hartman, N.R.; Balzarini, J.; Johns, D.G. Mol. Pharmacol. 1990, 37, 157-163.
21. (a) Cooney, D.A.; Ahluwalia, G.; Mitsuya, H.; Fridland, A.; Johnson, M.A.; Hao, Z.; Dalal, M.; Balzarini, J.; Broder, S.; Johns, D.G. Biochem. Pharmacol. 1987, 36, 1765-1768.
22. (b) Bloch, A.; Robins, M.J.; McCarthy, J.R., Jr. J. Med. Chem. 1967, 10, 908-912.
23. Johnson, M.A.; Ahluwalia, G.; Connelly, M.C.; Cooney, D.A.; Broder, S.; Johns, D.G. J. Biol. Chem. 1988, 263, 15354-15357.
24. Mitsuya, H.; Weinhold, K.J.; Furman, P.A.; St. Clair, M.H.; Nusinoff-Lehrman, S.; Gallo, R.C.; Bolognesi, D.; Barry, D.W.; Broder, S. Proc. Natl. Acad. Sci., USA 1985, 82, 7096-7100.
25. (a) Cinatl Jr, J.; Gröschel, B.; Zehner, R.; Cinatl, J.; Périgaud, C.; Gosselin, G.; Imbach, J.-L.; Doerr, H.W. Antiviral Chem. & Chemother. 1997, 8, 343-352.
26. (b) Dianzani, F.; Antonelli, G.; Turriziani, O.; Riva, E.; Swimeoni, E.; Signoretti, C.; Strosselli, S.; Cianfriglia, M. AIDS Res. Human Retroviruses 1994, 10, 1471-1478.
27. A more extensive overview of older nucleoside and nucleotide prodrugs summarizing also part of the tripartate prodrug concepts can be found in: Jones, R.J.; Bischofberger, N. Antiviral Res. 1995, 27, 1-17 and cited literature.
28. (b) Périgaud, C.; Giradet, J.-L.; Gosselin, G.; Imbach, J.-L. in: Advances in Antiviral Drug Design. (Ed. De Clercq, E.), 1996, Vol. 2, 147-172.
29. (c) Gosselin, G.; Imbach, J.-L. Int. Antiviral News 1993, 1, 100-102.
30. (a) Stella, V.J. J. Med. Chem. 1980, 23, 1275-1285.
31. (b) Sinkula, A.A.; Yalkowsky, S.H. J. Pharm. Sci. 1980, 64, 181-210.
32. Carl, P.L.; Chakravarty, P.K.; Katzenellenbogen, J.A. J. Med. Chem. 1981, 24, 479-480.
33. Holmstedt, B. Pharmacol. Rev. 1959, 11, 569-618.
34. (a) Aldridge, W.; Davison, A. Biochem. J. 1952, 51, 62-70.
35. (b) Ashini, Y.; Snyder, S.; Wilson, I. J. Med. Chem. 1973, 16, 446.
36. It is well known in literature that phosphodiesters are extremely stable against chemical hydrolysis at physiological pH values: Bunton, C.A.; Mhala, M.M.; Oldham, K.G.; Vernon, C.A. J. Chem. Soc. 1960, 3293-3301.
37. Even the "reactive" diphenylphosphate showed a half live of 180 years(!) at pH 7.0 and 100°C: Kirby, A.J.; Younas, M. J. Chem. Soc. (B) 1970, 510-513.
38. (a) Westheimer, F.H. Acc. Chem. Res. 1968, 1, 70-78.
39. (b) Buchwald, S.L. Pliura, D.H.; Knowles, J.R. J. Am. Chem. Soc. 1984, 106, 4916-4922.
40. Srinivas, R.V.; Robbins, B.L.; Connelly, M.C.; Gong, Y.-F.; Bischofberger, N.; Fridland, A. Int. Antiviral News 1994, 2, 53-55.
41. Farquhar, D.; Srivastava, D.N.; Kattesch, N.J.; Saunders, P.P. J. Pharm. Sci. 1983, 72, 324-325.
42. Sastry, J.K.; Nehete, P.N.; Khan, S.; Nowak, B.J.; Plunkett, W.; Arlinghaus, R.B.; Farquhar, D. Mol. Pharmacol. 1992, 41, 441-445.
43. Pompon, A.; Lefebvre, L; Imbach, J.-L.; Khan, S.; Farquhar, D. Antiviral Chem. Chemother. 1994, 5, 91-98.
44. Srinivas, R.V.; Robbins, B.L.; Connelly, M.C.; Gong, Y.-R; Bischofberger, N.; Fridland, A. Antimicrob. Agents Chemother. 1993, 37, 2247-2250.
45. (a) Farquhar, D.; Khan, S.; Srivastva, D.M.; Saunders, P.P. J. Med. Chem. 1994, 37, 3902- 3909.
46. (b) Farquhar, D.; Chen, R.; Khan, S. J. Med. Chem. 1995, 38, 488-495.
47. Jones, R.J.; Arimilli, M.N.; Lin, K.-Y.; Louie, M.S.; McGee, L.R.; Shaw, J.-P.; Burman, D.; Lee, M.; Kennedy, J.A.; Prisbe, E.J.; Bischofberger, N.; Lee, W.A.; Cundy, K.C. Abstract OP11; XII International Roundtable Nucleosides, Nucleotides and their biological Application, September 15-19, 1996, La Jolla, USA.
48. (a) Arimilli, M.N.; Kim, C.U.; Dougherty, J.; Mulato, A.; Oliyai, R.; Shaw, J. P.; Cundy, K. C.; Bischofberger, N.; Antiviral Chem. & Chemother. 1997, 8, 557-564.
49. (b) Fridland, A.; Robbins, B.L.; Srinivas, R. V.; Arimilli, M.; Kim, C.; Bischofberger, N. Antiviral Res. 1997, 34, A49, 27.
50. Naesens, L.; Bischofberger, N.; Arimilli, M.; Kim, C.; De Clercq, E. Antiviral Res. 1997, 34, A50, 28;
51. Work presented at the 10th International Conference on Antiviral Research, April 6-11, 1997, Atlanta, Georgia, USA.
52. (a) Périgaud, C.; Gosselin, G.; Imbach, J.-L. Curr. Topics in Med. Chem. 1997, 2, 15-29.
53. (b) Gosselin, G.; Giradet, J.-L.; Périgaud, C.; Benzaria, S.; Lefebvre, L; Schlienger, N.; Pompon, A.; Imbach, J.-L. Acta Biochim. Pol. 1996, 43, 195-208.
54. (c) Puech, F.; Gosselin, G.; Lefebvre, I.; Pompon, A.; Aubertin, A.-M.; Kirn, A.; Imbach, J.-L. Antiviral Res. 1993, 22, 155-174.
55. (d) Valette, G.; Pompon, A.; Girardet, J.-L.; Cappellacci, L.; Franchetti, P.; Grifantini, M.; La Colla, P.; Loi, A. G.; Périgaud, C.; Gosselin, G.; Imbach, J.-L. J. Med. Chem. 1996, 39, 1981-1990.
56. Giradet, J.-L.; Gosselin, G.; Périgaud, C.; Balzarini, J.; De Clercq, E.; Imbach, J.-L. Nucleosides &. Nucleotides 1995, 14, 645-647.
57. (a) Benzaria, S.; Pélicano, H.; Johnson, R.; Maury, G.; Imbach, J.-L., Aubertin, A.-M.; Obert, G.; Gosselin, G. J. Med. Chem. 1996, 39, 4958-4965.
58. (b) Benzaria, S.; Gosselin, G.; Pélicano, H.; Maury, G.; Aubertin, A.-M.; Obert, G.; Kirn, A.; Imbach, J.-L. Nucleosides & Nucleotides 1995, 14, 563-565.
59. Pugaeva, V.P.; Klochkeva, S.I.; Mashbits, F.D.; Eizengart, R.S. Gig. Tr. Prof. Zabol. 1969, 13, 47-48
60. (Chem. Abstract 72, 212).
61. Luethy, J.; Von Daeniken, A.; Friedrich, U.; Manthey, B.; Zweifel, U.; Schlatter, C.; Benn, M.H. Mitt. Geb. Lebensmittelunters. Hyg. 1981, 72, 131-133
62. (Chem. Abstracts 95, 127093).
63. Périgaud, C.; Girardet, J.-L.; Lefebvre, I.; Xie, M.-Y.; Aubertin, A.-M.; Kirn, A.; Gosselin, G.; Imbach, J.-L.; Sommadoussi, J.-P. Antiviral Chem. & Chemother. 1996, 7, 338-345.
64. (a) Lefebvre, I.; Périgaud, C.; Pompon, A.; Aubertin, A.-M.; Girardet, J.-L.; Kirn, A.; Gosselin, G.; Imbach. J.-L. J. Med. Chem. 1995, 38, 3941-3950.
65. (b) Lefebvre, I.; Pompon, A.; Périgaud, C.; Girardet, J.-L.; Gosselin, G.; Aubertin, A.-M.; Kirn, A.; Imbach, J.-L. Nucleosides & Nucleotides 1995, 14, 763-766.
66. Girardet, J.-L.; Périgaud, C.; Aubertin, A.-M.; Gosselin, G.; Kirn, A.; Imbach, J.-L. Bioorg. Med. Chem. Lett. 1995, 5, 2981-2984.
67. (a) Périgaud, C.; Aubertin, A.-M.; Benzaria, S.; Pelicano, H.; Girardet, J.-L.; Maury, G.; Gosselin, G.; Kirn, A.; Imbach, J.-L. Biochem. Pharmacol. 1994, 48, 11-14.
68. (b) Périgaud, C.; Gosselin, G.; Benzaria, S.; Girardet, J.-L.; Maury, G.; Pélicano, H.; Aubertin, A.-M.; Kirn, A.; Imbach, J.-L. Nucleosides & Nucleotides 1995, 14, 789-791.
69. Schlienger, N.; Périgaud, C.; Gosselin, G.; Imbach, J.-L. Work presented at the 12th International Round Table Nucleosides, Nucleotides & their biological Application, September 15-19, 1996, La Jolla, USA.
70. Schlienger, N.; Périgaud, C.; Gosselin, G.; Lefebvre, I.; Pompon, A.; Aubertin, A.-M.; Kirn, A.; Imbach, J.-L. Work presented at the 12th International Round Table Nucleosides, Nucleotides & their biological Application, September 15-19, 1996, La Jolla, USA.
71. Routledge, A.; Walker, I.; Freeman, S.; Hay, A.; Mahmood, N. Nucleosides & Nucleotides 1995, 14, 1545-1558.
72. (a) Glazier, A.; Kwong, C.; Rose, J.; Buckheit, R. Antiviral Res. 1992, 17, (Suppl. 1), 66.
73. (b) Glazier, A.; Buckheit, R.; Yanachkova, M.; Yanachkov, I.; Wright, G.E. Antiviral Res. 1994, 19, (Suppl. 1), 57.
74. Thomson, W.; Nicholls, D.; Irwin, W.J.; Al-Mushadani, J.S.; Freeman, S.; Karpas, A.; Petrik, J. J. Chem. Soc., Perkin Trans, 1 1993, 1239-1244.
75. (a) Thomson, W.; Nicholls, D.; Mitchell, A.G.; Corner, J.A.; Irwin, W.J.; Freeman, S. J. Chem. Soc., Perkin Trans, 1 1993, 2303-2308.
76. (b) Mitchell, A.G.; Nicholls, D.; Irwin, W.J.; Freeman, S. J. Chem. Soc., Perkin Trans. 2 1992, 1145-1150.
77. (c) Mitchell, A.G.; Thomson, W.; Nicholls, D.; Irwin, W.J.; Freeman, S. J. Chem. Soc., Perkin Trans 1, 1992, 2345-2353.
78. Briggs, A.D.; Camplo, M.; Freeman, S.; Lundström, J.; Pring, B.C. Tetrahedron, 1996, 47, 14937-14950.
79. Filar, L.; Winstein, S. Tetrahedron Lett. 1960, 25, 9-16.
80. Glazier, A.; Yanachkova, M.; Yanachkov, I.; Wright, G.E.; Kern, E.R.; Sidwell, R.; Smee, D.; McKeough, M.; Spruance, S.L. Work presented at the 9th International Conference on Antiviral Research, May 19-24, 1996, in Urabandai, Fukushima, Japan.
81. McGuigan, C.; Camarasa, M.-J.; Egberink, H.; Hartmann, K.; Karlsson, A.; Perno, C.F.; Balzarini, J. Int. Antiviral News 1997, 5, 19-21.
82. McGuigan, C.; Cahard, D.; Sheeka, H.M.; De Clercq, E.; Balzarini, J. J. Med. Chem. 1996, 59, 1748-1753.
83. McGuigan, C.; Pathirana, R.N.; Balzarini, J.; De Clercq, E.; J. Med. Chem. 1993, 36, 1048-1052.
84. Balzarini, J.; Wedgwood, O.M.; Kruining, J.; Pelemans, H.; Heijtink, R.; De Clercq, E.; McGuigan, C. Biochem. Biophys. Res. Commun. 1996, 225, 363-369.
85. Balzarini, J.; Kruining, J.; Wedgwood, O.; Pannecouque, C.; Aquaro, S.; Perno, C.-F.; Naesens, L.; Witvrouw, M.; Heijtink, R.; De Clercq, E.; McGuigan, C. FEBS Letters 1997, 410, 324-328.
86. McGuigan, C.; Wedgwood, O.M.; De Clercq, E.; Balzarini, J. Bioorg. Med. Chem. Lett. 1996, 6, 2359-2362.
87. Balzarini, J.; Egberink, H.; Hartmann, K.; Karlsson, A.; Perno, C.-F.; Cahard, D.; Naesens, L.; Thormar, E.; De Clercq, E.; McGuigan, C. Antiviral Res. 1996, 30, A18, 3;
88. Work presented at the 9th International Conference on Antiviral Research, May 19-24, 1996, in Urabandai, Fukushima, Japan.
89. McGuigan, C.; Cahard, D.; Salgado, A.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 1996, 7, 31-36.
90. McGuigan, C.; Tsang, H.-W.; Cahard, D.; Turner, K.; Velazquez, S.; Salgado, A.; Bidois, L.; Naesens, L.; De Clercq, E.; Balzarini, J. Antiviral Res. 1997, 35, 195-204.
91. McGuigan, C.; Salgado, A.; Yarnold, C.; Harries, T.Y.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 1996, 7, 184-188.
92. (a) Balzarini, J.; Karlsson, A.; Aquaro, S.; Perno, C.-F.; Cahard, D.; Naesens, L.; De Clercq, E.; McGuigan, C. Proc. Natl. Acad. Sci., USA 1996, 93, 7295-7299.
93. (b) Balzarini, J.; Egberink, H.; Hartmann, K.; Cahard, D.; Vahlenkamp, T.; Thormar, E.; De Clercq, E.; McGuigan, C. Mol. Pharmacol. 1996, 50, 1207-1213.
94. Naesens, L.; Cahard, D.; Salgado, A.; Bidois, L.; De Clercq, E.; McGuigan, C.; Balzarini, J. Antiviral Res. 1997, 34, A54, 40;
95. Work presented at the 10th International Conference on Antiviral Research, April 6-11, 1997 in Atlanta, Georgia, USA.
96. Abraham, T.W.; Wagner, C.R. Nucleosides & Nucleotides 1994, 13, 1891-1903.
97. Wagner, C.R.; McIntee, E.J.; Schinazi, R.F.; Abraham, T.W. Bioorg. Med. Chem. Letters 1995, 5, 1819-1824.
98. Abraham, T.W.; Kalman, T.I.; McIntee, E.J.; Wagner, C.R. J. Med. Chem. 1996, 39, 4569-4575.
99. McIntee, E.J.; Remmel, R.P.; Schinazi, R.F.; Abraham, T.W.; Wagner, C.R. J. Med. Chem. 1997, 40, 3323-3331
100. and Wagner, C.R. Antiviral Res. 1997, 34, A61, 68;
101. work presented at the 10th International Conference on Antiviral Research, April 6-11, 1997 in Atlanta, Georgia, USA.
102. Meier C. Angew. Chem. 1996, 108, 77-79;
103. Angew. Chem. Int. Ed. Engl. 1996, 35, 70-72.
104. Meier, C.; Knispel, T.; Lorey, M.; Balzarini, J. Int. Antiviral News 1997, 5, 183-185.
105. Meier, C. University of Würzburg, unpublished results.
106. (a) Meier, C.; Lorey, M.; De Clercq, E.; Balzarini, J. Bioorg. Med. Chem. Lett. 1997, 7, 99-104.
107. (b) Meier, C.; Lorey, M.; De Clercq, E.; Balzarini, J. Nucleosides & Nucleotides 1997, 16, in press.
108. (c) Meier, C.; Lorey, M.; De Clercq, E.; Balzarini, J. J. Med. Chem. 1997, submitted.
109. Meier, C.; Knispel, T.; De Clercq, E.; Balzarini, J. Bioorg. Med. Chem. Lett. 1997, 7, 1577-1582.
110. Farrow, S.N.; Jones, A.S.; Kumar, A.; Walker, R.T.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1990, 33, 1400-1406.
111. Meier, C.; Habel, L.W.; Balzarini, J.; De Clercq, E. Liebigs Annalen der Chemie 1995, 2203-2208.
112. (a) Meier, C.; De Clercq, E.; Balzarini, J. Liebig Annalen der Chemie 1997, submitted.
113. (b) Meier, C.; De Clercq, E.; Balzarini, J. Nucleosides & Nucleotides 1997, 16, 793-796.
114. Lorey, M.; Meier, C.; De Clercq, E.; Balzarini, J. Nucleosides & Nucleotides 1997, 16, 789-792.